Summary

The companion animal diagnostics market is expected to grow from USD 3.56 billion in 2026 to USD 5.40 billion by 2031, at a CAGR of 8.7%. This growth is driven by several key factors shaping the future of diagnostic technology, preventive care, and precision veterinary medicine.

key catalyst is the growing need for sophisticated diagnostic platforms as veterinary healthcare organizations seek to improve the accuracy, speed, and efficiency of current diagnostic processes. With the increasing need for a targeted, data-focused approach in companion animal healthcare, demand for high-quality diagnostic platforms is rising. Moreover, the need to shift focus to preventive healthcare and targeted disease management is being fueled by the growing demand for innovative diagnostic platforms. This trend is being augmented by AI-driven data analysis and cloud services, resulting in demand for innovative GMP-compliant diagnostic platforms.

Furthermore, the increasing incidence of chronic, infectious, and age-related diseases in domesticated pets is fueling the need for rapid, efficient diagnostic options. Veterinarians and veterinary labs are increasingly seeking support from specialty diagnostic companies to meet the ever-rising volume of cases through high-throughput testing, molecular testing, and imaging capabilities. The growing momentum toward modernizing the field of vet care, driven by real-time monitoring tools, artificial intelligence-powered predictive analytics, and cloud-based systems, is also fueling the need for new, high-quality diagnostic services.

Advances in technology, including automated analyzers, point-of-care testing, and AI interpretation, are fueling the market by improving test accuracy and turnaround times and expanding testing available in the companion animal space. With more of the companion animal diagnostics space outsourcing expertise in complex animal diagnoses or animal research, these advances also support the continued evolution of the companion animal diagnostics market.

"By technology, molecular diagnostics segment to register the highest CAGR during forecast period."
The molecular diagnostics segment is expected to see the highest growth in the companion animal diagnostics market due to its ability to deliver accurate results for infectious diseases, genetic disorders, and cancers in pet animals. Improvements in PCR, next-generation sequencing, and liquid biopsy have increased the use of molecular diagnostics, enabling veterinarians to easily test their patients for complex ailments that were previously hard to identify. Additionally, there is a growing need for precision medicine, which requires precise diagnostic methods to provide tailored treatment plans for pets.

"By product, consumables segment accounted for larger market share in 2025."
In 2025, the consumables segment dominated the companion animal diagnostics market, as reagents, test kits, and diagnostic strips are indispensable components of most tests performed in veterinary labs and animal health centers. Those consumables are used in everyday tests conducted for companion animals, including blood and urinalysis tests. Point-of-care and in-house testing are also widely adopted in the companion animal industry, and these consumables are used on a day-to-day basis. Furthermore, as the need to test animals increases and vet practices move toward preventive testing, there will be a growing demand for consumables, thereby maintaining their dominant market position.

“Asia Pacific to witness highest growth rate during forecast period.”
The Asia Pacific region is expected to witness the fastest growth in the companion animal diagnostics market during the forecast period, driven by the growing number of pet lovers who are spending heavily on their pets. With greater awareness of animal health and higher spending capacity among pet owners, the Asia Pacific market is growing rapidly. The increased use of advanced animal diagnostic equipment, such as point-of-care testing and molecular diagnostics, is meeting the need for high-quality diagnostics at affordable prices. Moreover, advances in animal healthcare infrastructure and animal insurance coverage are driving the animal diagnostics market in the Asia Pacific region.

Breakdown of supply-side primary interviews:
? By Company Type: Tier 1 (60%), Tier 2 (30%), and Tier 3 (10%)
? By Designation: C-level Executives (30%), Directors (50%), and Other Designations (20%)
? By Region: North America (45%), Europe (15%), Asia Pacific (25%), Latin America (10%), and the Middle East & Africa (5%)

Breakdown of demand-side primary interviews:
? By End User: Diagnostic Laboratories (45%), Veterinary Hospitals & Clinics (30%), Veterinary Research Institutes & Universities (15%), and Home Care Settings (10%)
By Designation: Veterinary Clinicians (47%), Diagnostic Laboratory Directors/Managers (22%), R&D Directors/Product Development Heads (15%), and Others (16%)
? By Region: North America (25%), Europe (24%), Asia Pacific (25%), Latin America (11%), and the Middle East & Africa (15%)

Research Coverage
The market study covers the companion animal diagnostics market in various segments. It aims to estimate the market size and growth potential by product, technology, application, animal type, end user, and region. The study also includes an in-depth competitive analysis of the market's key players, along with their company profiles, key observations on their products and business offerings, recent developments, and key market strategies.

Reasons to Buy Report
The report can assist established companies and newer or smaller firms in understanding market trends, enabling them to capture a larger share of the market. Firms that acquire the report can implement one or more of the five strategies outlined below.

This report provides insights into the following points:
? Analysis of key drivers (growth in the companion animal population, rising demand for pet insurance, and increased spending on animal healthcare), restraints (high cost of diagnostic devices, stringent regulations and lengthy approval processes for diagnostic products), opportunities (growing demand for rapid tests and portable instruments for POC diagnostics, integration of AI and ML for enhanced disease diagnosis), and challenges (shortage of veterinary practitioners in emerging markets, barriers to adoption in small clinics) influencing the growth of the companion animal diagnostics market.
? Product Development/Innovation: Detailed insights on upcoming technologies and product launches in the companion animal diagnostics market.
? Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of companion animal diagnostic products across regions.
? Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the companion animal diagnostics market.
? Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the companion animal diagnostics market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 46
1.1 STUDY OBJECTIVES 46
1.2 MARKET DEFINITION 46
1.3 STUDY SCOPE 46
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 47
1.3.2 INCLUSIONS & EXCLUSIONS 48
1.3.3 YEARS CONSIDERED 49
1.3.4 CURRENCY CONSIDERED 49
1.3.5 UNITS CONSIDERED 49
1.4 MARKET STAKEHOLDERS 49
1.5 SUMMARY OF CHANGES 50
2 EXECUTIVE SUMMARY 53
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 53
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 54
2.3 DISRUPTIVE TRENDS IN COMPANION ANIMAL DIAGNOSTICS MARKET 55
2.4 HIGH-GROWTH SEGMENTS 56
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 57
3 PREMIUM INSIGHTS 58
3.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW 58
3.2 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT & COUNTRY (2025) 59
3.3 COMPANION ANIMAL DIAGNOSTICS MARKET: REGIONAL MIX 60
3.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 61
3.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 62
4 MARKET OVERVIEW 63
4.1 INTRODUCTION 63
4.2 MARKET DYNAMICS 63
4.2.1 DRIVERS 64
4.2.1.1 Growth in companion animal population 64
4.2.1.2 Increasing demand for pet insurance and growth in animal healthcare expenditure 65
4.2.1.3 Growing number of veterinary practitioners 66
4.2.1.4 Increasing prevalence of infectious, parasitic, and chronic diseases in pets 67
?
4.2.2 RESTRAINTS 68
4.2.2.1 Rising pet care costs 68
4.2.2.2 Limited access to advanced veterinary diagnostic services in developing regions 69
4.2.3 OPPORTUNITIES 69
4.2.3.1 Growing demand for rapid tests and portable instruments for POC diagnostics 69
4.2.3.2 Utilization of AI and ML for enhanced disease diagnosis 70
4.2.4 CHALLENGES 70
4.2.4.1 Low awareness regarding preventive diagnostics among pet owners in price-sensitive markets 70
4.2.4.2 Regulatory and reimbursement limitations in veterinary healthcare diagnostics 71
4.3 UNMET NEEDS & WHITE SPACES 72
4.3.1 UNMET NEEDS IN COMPANION ANIMAL DIAGNOSTICS MARKET 72
4.3.2 WHITE SPACE OPPORTUNITIES 72
4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 73
4.4.1 INTERCONNECTED MARKETS 73
4.4.2 CROSS-SECTOR OPPORTUNITIES 74
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74
4.5.1 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 74
5 INDUSTRY TRENDS 75
5.1 PORTER’S FIVE FORCES ANALYSIS 75
5.1.1 THREAT OF NEW ENTRANTS 76
5.1.2 THREAT OF SUBSTITUTES 76
5.1.3 BARGAINING POWER OF SUPPLIERS 77
5.1.4 BARGAINING POWER OF BUYERS 77
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.2 MACROECONOMIC INDICATORS 78
5.2.1 INTRODUCTION 78
5.2.2 GDP TRENDS & FORECAST 78
5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 80
5.2.4 TRENDS IN GLOBAL ANIMAL HEALTH INDUSTRY 80
5.3 VALUE CHAIN ANALYSIS 80
5.4 ECOSYSTEM ANALYSIS 82
5.5 PRICING ANALYSIS 83
5.5.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER, 2023?2025 84
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023?2025 85
5.5.2.1 Average selling price trend of rapid test kits, by region, 2023?2025 86
5.5.2.2 Average selling price trend of ELISA/immunodiagnostic test kits & reagents, by region, 2023?2025 86
5.5.2.3 Average selling price trend of clinical chemistry reagents, clips & cartridges, by region, 2023?2025 86
5.5.2.4 Average selling price trend of blood glucose strips, by region, 2023?2025 87
5.5.2.5 Average selling price trend of hematology analyzers, by region, 2023?2025 87
5.6 TRADE ANALYSIS 87
5.6.1 TRADE DATA FOR HS CODE 9018 88
5.6.1.1 Import data for HS Code 9018 88
5.6.1.2 Export data for HS Code 9018 88
5.6.2 TRADE DATA FOR HS CODE 3822 89
5.6.2.1 Import data for HS Code 3822 89
5.6.2.2 Export data for HS Code 3822 89
5.7 KEY CONFERENCES & EVENTS, 2026?2027 90
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 91
5.9 INVESTMENT & FUNDING SCENARIO 92
5.10 SUCCESS STORIES & REAL-WORLD APPLICATIONS 93
5.10.1 NGS-BASED LIQUID BIOPSY FOR CANINE CANCER DETECTION 93
5.10.2 ADOPTION OF AI-ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION 93
5.10.3 DEVELOPMENT OF SNAP 4DX PLUS TEST FOR RAPID VECTOR-BORNE DISEASE DETECTION 94
5.11 IMPACT OF US TARIFFS?COMPANION ANIMAL DIAGNOSTICS MARKET 94
5.11.1 INTRODUCTION 94
5.11.2 KEY TARIFF RATES 96
5.11.3 PRICE IMPACT ANALYSIS 97
5.11.4 IMPACT ON COUNTRIES/REGIONS 98
5.11.5 IMPACT ON END-USE INDUSTRIES 99
5.11.5.1 Veterinary Hospitals & Clinics 99
5.11.5.2 Veterinary Reference Laboratories 100
5.11.5.3 Veterinary Research Institutes & Universities 100
5.11.5.4 Home Care Settings 100
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 101
6.1 KEY EMERGING TECHNOLOGIES 101
6.1.1 AI-ENABLED DIAGNOSTICS 101
6.1.2 PORTABLE INSTRUMENTS FOR POC DIAGNOSTIC SERVICES 101
6.2 COMPLEMENTARY TECHNOLOGIES 102
6.2.1 MICROFLUIDIC DEVICES FOR VETERINARY DIAGNOSTICS 102
6.2.2 CRISPR-BASED MOLECULAR DIAGNOSTICS 103
6.3 ADJACENT TECHNOLOGIES 103
6.3.1 WEARABLE BIOSENSORS & REMOTE MONITORING DEVICES 103
6.3.2 BREATH & SALIVA-BASED DIAGNOSTIC TOOLS 104
?
6.4 TECHNOLOGY/PRODUCT ROADMAP 104
6.4.1 NEAR TERM (2025?2027) 104
6.4.2 MID-TERM (2028?2030) 105
6.4.3 LONG TERM (2030+) 105
6.5 PATENT ANALYSIS 106
6.5.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTIC KITS 106
6.5.2 JURISDICTION & TOP APPLICANT ANALYSIS 107
6.6 FUTURE APPLICATIONS 108
6.6.1 AI-DRIVEN PREDICTIVE DIAGNOSTICS 108
6.6.2 FULLY INTEGRATED DIGITAL VETERINARY ECOSYSTEMS 108
6.6.3 PRECISION & PERSONALIZED VETERINARY DIAGNOSTICS 108
6.6.4 REMOTE & HOME-BASED PET HEALTH MONITORING 108
6.6.5 AUTOMATED HIGH-THROUGHPUT VETERINARY LABORATORIES 108
6.7 IMPACT OF AI/GENERATIVE AI ON COMPANION ANIMAL DIAGNOSTICS MARKET 109
6.7.1 INTRODUCTION 109
6.7.2 MARKET POTENTIAL IN COMPANION ANIMAL DIAGNOSTIC ECOSYSTEM 109
6.7.3 AI USE CASES 110
6.7.4 KEY COMPANIES IMPLEMENTING AI IN COMPANION ANIMAL DIAGNOSTICS MARKET 110
7 REGULATORY LANDSCAPE & SUSTAINABILITY INITIATIVES 112
7.1 REGIONAL REGULATIONS & COMPLIANCE 112
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
7.1.1.1 North America 113
7.1.1.2 Europe 114
7.1.1.3 Rest of the world 115
7.1.2 INDUSTRY STANDARDS 116
7.2 SUSTAINABILITY INITIATIVES 117
7.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR COMPANION ANIMAL DIAGNOSTIC PRODUCTS 117
7.2.2 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES 117
7.2.3 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 118
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 119
8.1 KEY STAKEHOLDERS & BUYING CRITERIA 119
8.1.1 KEY STAKEHOLDERS IN BUYING PROCESS 119
8.1.2 BUYING CRITERIA 120
8.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 121
8.2.1 DECISION-MAKING PROCESS 121
8.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES 122
8.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 122
8.2.4 MARKET PROFITABILITY 123
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT 124
9.1 INTRODUCTION 125
9.2 CONSUMABLES 125
9.2.1 RECURRING NATURE TO BOOST DEMAND 125
9.3 INSTRUMENTS 128
9.3.1 INCREASING DEMAND FOR POC ANALYZERS TO DRIVE MARKET 128
10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY 131
10.1 INTRODUCTION 132
10.2 IMMUNODIAGNOSTICS 132
10.2.1 LATERAL FLOW ASSAYS 136
10.2.1.1 Rapid tests 138
10.2.1.1.1 Growing prevalence of infectious diseases in pets to fuel demand 138
10.2.1.1.2 Global volume analysis of rapid tests,
2024?2031 (thousand units) 140
10.2.1.2 Strip readers 140
10.2.1.2.1 Advancements in digital and AI-enabled diagnostics to support adoption 140
10.2.1.2.2 Global volume analysis of strip readers,
2024?2031 (thousand units) 142
10.2.2 ELISA TESTS 143
10.2.2.1 Higher sensitivity and specificity of ELISA testing to support market expansion 143
10.2.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 145
10.2.3.1 Rising incidence of allergies and dermatological conditions to fuel market growth 145
10.2.4 IMMUNOASSAY ANALYZERS 147
10.2.4.1 Increasing automation in veterinary diagnostics to drive market growth 147
10.2.5 RADIOIMMUNOASSAYS 149
10.2.5.1 Growing demand for sensitive hormone and endocrine testing to fuel market 149
10.2.6 OTHER IMMUNODIAGNOSTICS PRODUCTS 151
10.3 CLINICAL BIOCHEMISTRY 152
10.3.1 CLINICAL CHEMISTRY ANALYSIS 155
10.3.1.1 Clinical chemistry reagents, clips, and cartridges 157
10.3.1.1.1 Increasing utilization of consumable-based diagnostic workflows to fuel market 157
10.3.1.1.2 Global volume analysis of clinical chemistry reagents, clips, and cartridges, 2024?2031 (thousand units) 159
10.3.1.2 Clinical chemistry analyzers 159
10.3.1.2.1 Growing adoption of in-house veterinary diagnostics to drive analyzer demand 159
10.3.1.2.2 Global volume analysis of clinical chemistry analyzers, 2024?2031 (thousand units) 161
10.3.2 BLOOD GAS & ELECTROLYTE ANALYSIS 162
10.3.2.1 Blood gas and electrolyte reagents, clips, and cartridges 164
10.3.2.1.1 Rising demand for rapid point-of-care consumables to boost market 164
10.3.2.1.2 Global volume analysis of blood gas & electrolyte reagents, clips, and cartridges, 2024?2031 (thousand units) 166
10.3.2.2 Blood gas & electrolyte analyzers 166
10.3.2.2.1 Increasing adoption of compact critical-care analyzers in veterinary clinics to drive market 166
10.3.2.2.2 Global volume analysis of blood gas & electrolyte analyzers, 2024?2031 (thousand units) 168
10.3.3 GLUCOSE MONITORING 169
10.3.3.1 Blood glucose strips 171
10.3.3.1.1 Increasing home-based diabetes management to fuel market 171
10.3.3.1.2 Global volume analysis of blood glucose strips, 2024?2031 (thousand units) 173
10.3.3.2 Glucose monitors 173
10.3.3.2.1 Advancements in portable and continuous glucose monitoring technologies to drive market growth 173
10.3.3.2.2 Global volume analysis of glucose monitors,
2024?2031 (thousand units) 175
10.3.3.3 Urine glucose strips 175
10.3.3.3.1 Cost-effective and non-invasive diabetes screening to propel market 175
10.3.3.3.2 Global volume analysis of urine glucose strips,
2024?2031 (thousand units) 177
10.4 MOLECULAR DIAGNOSTICS 178
10.4.1 PCR TESTS 180
10.4.1.1 Increasing prevalence of infectious diseases in companion animals to support growth 180
10.4.2 MICROARRAYS 183
10.4.2.1 Growing focus on genomic profiling and multiplex testing to drive market 183
10.4.3 NUCLEIC ACID SEQUENCING 184
10.4.3.1 Expanding applications of genomic analysis in veterinary medicine to drive demand 184
10.4.4 OTHER MOLECULAR DIAGNOSTICS PRODUCTS 186
10.5 URINALYSIS 187
10.5.1 URINALYSIS CLIPS & CARTRIDGES 189
10.5.1.1 Growing use of consumable-based urine testing workflows to drive growth 189
10.5.2 URINE ANALYZERS 191
10.5.2.1 Increasing automation in veterinary urinalysis testing to support market growth 191
10.5.3 URINE TEST STRIPS 193
10.5.3.1 Rising demand for rapid and cost-effective urine screening tests to drive market 193
10.6 HEMATOLOGY 195
10.6.1 HEMATOLOGY CARTRIDGES 197
10.6.1.1 Rising use of disposable consumables in automated hematology workflows to fuel demand 197
10.6.2 HEMATOLOGY ANALYZERS 199
10.6.2.1 Growing demand for rapid complete blood count testing to support market growth 199
10.7 OTHER TECHNOLOGIES 201
11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 203
11.1 INTRODUCTION 204
11.2 CLINICAL PATHOLOGY 205
11.2.1 INCREASING PREVENTIVE HEALTH SCREENING AND CHRONIC DISEASE MONITORING DRIVES DEMAND 205
11.3 BACTERIOLOGY 207
11.3.1 RISING BACTERIAL INFECTIONS AND ANTIMICROBIAL RESISTANCE CONCERNS BOOST MARKET GROWTH 207
11.4 VIROLOGY 209
11.4.1 GROWING PREVALENCE OF COMPANION ANIMAL VIRAL DISEASES DRIVES GROWTH 209
11.5 PARASITOLOGY 211
11.5.1 INCREASING PARASITIC AND VECTOR-BORNE DISEASE BURDEN SUPPORTS DIAGNOSTIC ADOPTION 211
11.6 OTHER APPLICATIONS 213
12 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 215
12.1 INTRODUCTION 216
12.2 DOGS 217
12.2.1 RISING PREVALENCE OF CANINE CHRONIC AND VECTOR-BORNE DISEASES DRIVES DIAGNOSTIC DEMAND 217
12.3 CATS 219
12.3.1 GROWING AWARENESS OF FELINE INFECTIOUS AND KIDNEY DISEASES BOOSTS MARKET GROWTH 219
12.4 HORSE 222
12.4.1 INCREASING EQUINE HEALTH MONITORING SUPPORTS DIAGNOSTIC ADOPTION 222
12.5 OTHER COMPANION ANIMALS 224
?
13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER 226
13.1 INTRODUCTION 227
13.2 VETERINARY HOSPITALS & CLINICS 227
13.2.1 EXPANDING ADOPTION OF IN-HOUSE POINT-OF-CARE DIAGNOSTIC SOLUTIONS TO DRIVE MARKET 227
13.3 VETERINARY REFERENCE LABORATORIES 229
13.3.1 RISING DEMAND FOR SPECIALIZED AND HIGH-COMPLEXITY VETERINARY DIAGNOSTIC TESTING TO PROPEL MARKET 229
13.4 VETERINARY RESEARCH INSTITUTES & UNIVERSITIES 231
13.4.1 INCREASING RESEARCH FOCUS ON PRECISION AND MOLECULAR VETERINARY DIAGNOSTICS TO SUPPORT GROWTH 231
13.5 HOME CARE SETTINGS 233
13.5.1 GROWING ADOPTION OF AT-HOME PET HEALTH MONITORING AND DIAGNOSTIC TECHNOLOGIES TO BOOST DEMAND 233
14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION 235
14.1 INTRODUCTION 236
14.2 NORTH AMERICA 238
14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 239
14.2.2 NORTH AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024?2031 240
14.2.3 US 247
14.2.3.1 Rising preventive pet healthcare spending to drive market 247
14.2.4 CANADA 253
14.2.4.1 Increasing veterinary visits and growing pet population to drive market 253
14.3 EUROPE 260
14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 260
14.3.2 EUROPE: VOLUME ANALYSIS, BY PRODUCT, 2024?2031 261
14.3.3 GERMANY 268
14.3.3.1 Large companion animal population and premium veterinary care fuel market growth 268
14.3.4 UK 275
14.3.4.1 High veterinary expenditure and rising chronic pet diseases support diagnostics demand 275
14.3.5 FRANCE 281
14.3.5.1 Willingness of pet owners to spend on pet health to drive market 281
14.3.6 ITALY 287
14.3.6.1 Expansion of veterinary services supports market growth 287
14.3.7 SPAIN 294
14.3.7.1 Growing pet care economy and animal welfare initiatives to fuel market 294
14.3.8 NETHERLANDS 300
14.3.8.1 Developments in veterinary diagnostic products to support market growth 300
14.3.9 SWEDEN 306
14.3.9.1 Growing companion animal care and advanced veterinary infrastructure supporting market growth 306
14.3.10 POLAND 312
14.3.10.1 Expanding veterinary infrastructure and rising pet ownership support market development 312
14.3.11 REST OF EUROPE 318
14.4 ASIA PACIFIC 324
14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 325
14.4.2 ASIA PACIFIC: VOLUME ANALYSIS, BY PRODUCT, 2024?2031 327
14.4.3 CHINA 334
14.4.3.1 Growing urban pet population and rising adoption of pet insurance to propel market 334
14.4.4 JAPAN 340
14.4.4.1 Aging pet population and premium veterinary care to support market growth 340
14.4.5 INDIA 347
14.4.5.1 Expanding pet care industry and rising preventive healthcare awareness fuel market growth 347
14.4.6 AUSTRALIA 353
14.4.6.1 High veterinary expenditure and strong pet insurance penetration to support market growth 353
14.4.7 SOUTH KOREA 359
14.4.7.1 Digital veterinary healthcare expansion to drive market 359
14.4.8 THAILAND 365
14.4.8.1 Urban pet adoption and improving veterinary infrastructure to drive market 365
14.4.9 NEW ZEALAND 371
14.4.9.1 Strong animal welfare culture and preventive care trends support market expansion 371
14.4.10 REST OF ASIA PACIFIC 377
14.5 LATIN AMERICA 383
14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 383
14.5.2 LATIN AMERICA: VOLUME ANALYSIS, BY PRODUCT, 2024?2031 384
14.5.3 BRAZIL 390
14.5.3.1 Massive companion animal population to boost demand 390
14.5.4 MEXICO 396
14.5.4.1 High pet ownership and expanding veterinary services to support market growth 396
14.5.5 ARGENTINA 402
14.5.5.1 Strong pet humanization and preventive healthcare trends support market growth 402
14.5.6 REST OF LATIN AMERICA 408
?
14.6 MIDDLE EAST & AFRICA 414
14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 414
14.6.2 MIDDLE EAST & AFRICA: VOLUME ANALYSIS, BY PRODUCT, 2024?2031 415
14.6.3 GCC COUNTRIES 421
14.6.3.1 Kingdom of Saudi Arabia (KSA) 427
14.6.3.1.1 Government initiatives to drive market growth 427
14.6.3.2 United Arab Emirates (UAE) 433
14.6.3.2.1 Premium veterinary services and rising pet ownership to drive market 433
14.6.3.3 Rest of GCC Countries 439
14.6.4 REST OF MIDDLE EAST & AFRICA 445
15 COMPETITIVE LANDSCAPE 451
15.1 OVERVIEW 451
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 451
15.3 REVENUE ANALYSIS, 2021?2025 453
15.4 MARKET SHARE ANALYSIS, 2025 454
15.4.1 RANKING OF KEY MARKET PLAYERS 455
15.4.2 US MARKET SHARE ANALYSIS, 2025 457
15.4.3 EUROPE MARKET SHARE ANALYSIS, 2025 458
15.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 459
15.5.1 STARS 459
15.5.2 EMERGING LEADERS 459
15.5.3 PERVASIVE PLAYERS 459
15.5.4 PARTICIPANTS 459
15.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 461
15.5.5.1 Company footprint 461
15.5.5.2 Region footprint 462
15.5.5.3 Product footprint 463
15.5.5.4 Technology footprint 464
15.5.5.5 Animal type footprint 465
15.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 466
15.6.1 PROGRESSIVE COMPANIES 466
15.6.2 RESPONSIVE COMPANIES 466
15.6.3 DYNAMIC COMPANIES 466
15.6.4 STARTING BLOCKS 466
15.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 468
15.6.5.1 Detailed list of key startups/SMEs 468
15.6.5.2 Competitive benchmarking of key startups 469
15.7 BRAND/PRODUCT COMPARISON 470
15.8 R&D EXPENDITURE OF KEY PLAYERS 471
?
15.9 COMPANY VALUATION & FINANCIAL METRICS 471
15.9.1 FINANCIAL METRICS 471
15.9.2 COMPANY VALUATION 472
15.10 COMPETITIVE SCENARIO 472
15.10.1 PRODUCT LAUNCHES & ENHANCEMENTS 472
15.10.2 DEALS 473
15.10.3 EXPANSIONS 474
15.10.4 OTHER DEVELOPMENTS 475
16 COMPANY PROFILES 476
16.1 KEY PLAYERS 476
16.1.1 IDEXX LABORATORIES, INC. 476
16.1.1.1 Business overview 476
16.1.1.2 Products offered 477
16.1.1.3 Recent developments 478
16.1.1.3.1 Product launches & enhancements 478
16.1.1.4 MnM view 480
16.1.1.4.1 Key strengths 480
16.1.1.4.2 Strategic choices 480
16.1.1.4.3 Weaknesses & competitive threats 480
16.1.2 ANTECH DIAGNOSTICS, INC. 481
16.1.2.1 Business overview 481
16.1.2.2 Products offered 482
16.1.2.3 Recent developments 482
16.1.2.3.1 Product launches & approvals 482
16.1.2.3.2 Expansions 483
16.1.2.4 MnM view 484
16.1.2.4.1 Key strengths 484
16.1.2.4.2 Strategic choices 484
16.1.2.4.3 Weaknesses & competitive threats 484
16.1.3 ZOETIS SERVICES LLC 485
16.1.3.1 Business overview 485
16.1.3.2 Products offered 486
16.1.3.3 Recent developments 487
16.1.3.3.1 Product launches & enhancements 487
16.1.3.3.2 Deals 488
16.1.3.3.3 Expansions 489
16.1.3.3.4 Other developments 489
16.1.3.4 MnM view 490
16.1.3.4.1 Key strengths 490
16.1.3.4.2 Strategic choices 490
16.1.3.4.3 Weaknesses & competitive threats 490
16.1.4 FUJIFILM CORPORATION 491
16.1.4.1 Business overview 491
16.1.4.2 Products offered 493
16.1.4.3 MnM view 493
16.1.4.3.1 Key strengths 493
16.1.4.3.2 Strategic choices 494
16.1.4.3.3 Weaknesses & competitive threats 494
16.1.5 THERMO FISHER SCIENTIFIC INC. 495
16.1.5.1 Business overview 495
16.1.5.2 Products offered 496
16.1.5.3 MnM view 497
16.1.5.3.1 Key strengths 497
16.1.5.3.2 Strategic choices 497
16.1.5.3.3 Weaknesses & competitive threats 497
16.1.6 BIOM?RIEUX 498
16.1.6.1 Business overview 498
16.1.6.2 Products offered 499
16.1.6.3 Recent developments 500
16.1.6.3.1 Product launches & approvals 500
16.1.7 BIONOTE 501
16.1.7.1 Business overview 501
16.1.7.2 Products offered 501
16.1.7.3 Recent developments 504
16.1.7.3.1 Product launches & enhancements 504
16.1.7.3.2 Deals 506
16.1.8 VIRBAC 507
16.1.8.1 Business overview 507
16.1.8.2 Products offered 508
16.1.8.3 Recent developments 509
16.1.8.3.1 Deals 509
16.1.8.3.2 Expansions 510
16.1.9 RANDOX LABORATORIES LTD. 511
16.1.9.1 Business overview 511
16.1.9.2 Products offered 511
16.1.9.3 Recent developments 512
16.1.9.3.1 Deals 512
16.1.9.3.2 Expansions 513
16.1.10 INDICAL BIOSCIENCE GMBH 514
16.1.10.1 Business overview 514
16.1.10.2 Products offered 515
16.1.10.3 Recent developments 516
16.1.10.3.1 Product enhancements 516
16.1.11 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD. 517
16.1.11.1 Business overview 517
16.1.11.2 Products offered 517
16.1.11.3 Recent developments 518
16.1.11.3.1 Product launches 518
16.1.11.3.2 Expansions 519
16.1.12 BOULE 520
16.1.12.1 Business overview 520
16.1.12.2 Products offered 521
16.1.12.3 Recent developments 522
16.1.12.3.1 Product launches 522
16.1.12.3.2 Deals 523
16.1.13 INNOVATIVE DIAGNOSTICS 524
16.1.13.1 Business overview 524
16.1.13.2 Products offered 524
16.1.13.3 Recent developments 526
16.1.13.3.1 Other developments 526
16.1.14 MEGACOR DIAGNOSTIK GMBH 527
16.1.14.1 Business overview 527
16.1.14.2 Products offered 527
16.1.14.3 Recent developments 531
16.1.14.3.1 Product launches & enhancements 531
16.1.15 BIOGAL 533
16.1.15.1 Business overview 533
16.1.15.2 Products offered 533
16.2 OTHER PLAYERS 535
16.2.1 GOLD STANDARD DIAGNOSTICS 535
16.2.2 AGROLABO S.P.A. 536
16.2.3 PRECISION BIOSENSOR, INC. 538
16.2.4 SKYLA CORPORATION 539
16.2.5 FASSISI, GMBH 540
16.2.6 WOODLEY EQUIPMENT COMPANY LTD 541
16.2.7 BIOPANDA REAGENTS LTD 543
16.2.8 SKYER, INC. 544
16.2.9 RING BIOTECHNOLOGY CO., LTD. 545
16.2.10 SHENZHEN BIOEASY BIOTECHNOLOGY, INC. 546
?
17 RESEARCH METHODOLOGY 548
17.1 RESEARCH DATA 548
17.2 RESEARCH METHODOLOGY DESIGN 548
17.2.1 SECONDARY DATA 549
17.2.1.1 Key data from secondary sources 550
17.2.2 PRIMARY DATA 550
17.2.2.1 Key data from primary sources 551
17.2.2.2 Key industry insights 552
17.3 MARKET SIZE ESTIMATION 554
17.3.1 BOTTOM-UP APPROACH 559
17.4 MARKET BREAKDOWN AND DATA TRIANGULATION 561
17.5 MARKET SHARE ANALYSIS 562
17.5.1 RESEARCH ASSUMPTIONS 562
17.5.2 GROWTH RATE ASSUMPTIONS 562
17.6 RISK ASSESSMENT 563
17.7 RESEARCH LIMITATIONS 563
17.7.1 METHODOLOGY-RELATED LIMITATIONS 563
17.7.2 SCOPE-RELATED LIMITATIONS 563
18 APPENDIX 564
18.1 DISCUSSION GUIDE 564
18.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 570
18.3 CUSTOMIZATION OPTIONS 572
18.3.1 PRODUCT ANALYSIS 572
18.3.2 COMPANY INFORMATION 572
18.3.3 GEOGRAPHIC ANALYSIS 572
18.3.4 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS 572
18.3.5 COUNTRY-LEVEL VOLUME ANALYSIS BY PRODUCT 572
18.3.6 BY PRODUCT MARKET SHARE ANALYSIS (TOP 5 PLAYERS) 572
18.3.7 ANY CONSULT/CUSTOM REQUIREMENTS AS PER CLIENT REQUESTS 572
18.4 RELATED REPORTS 573
18.5 AUTHOR DETAILS 574

ページTOPに戻る

List of Tables/Graphs

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 49
TABLE 2 NUMBER OF US HOUSEHOLDS THAT OWN A PET IN 2025, BY ANIMAL TYPE (MILLIONS) 64
TABLE 3 AVERAGE PREMIUMS PAID IN US, 2023 VS. 2024 65
TABLE 4 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 76
TABLE 5 GDP CHANGE, BY KEY COUNTRY, 2021?2030 (USD BILLION) 79
TABLE 6 AVERAGE SELLING PRICE TREND OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, BY KEY PLAYER, 2023?2025 (USD) 84
TABLE 7 AVERAGE SELLING PRICE TREND OF RAPID TEST KITS, BY REGION, 2023?2025 86
TABLE 8 AVERAGE SELLING PRICE TREND OF ELISA/IMMUNODIAGNOSTIC TEST KITS & REAGENTS, BY REGION, 2023?2025 86
TABLE 9 AVERAGE SELLING PRICE TREND OF CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES, BY REGION, 2023?2025 86
TABLE 10 AVERAGE SELLING PRICE TREND OF BLOOD GLUCOSE STRIPS, BY REGION, 2023?2025 87
TABLE 11 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION, 2023?2025 87
TABLE 12 IMPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021?2025 (USD THOUSAND) 88
TABLE 13 EXPORT DATA FOR HS CODE 9018, BY COUNTRY, 2021?2025 (USD THOUSAND) 88
TABLE 14 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021?2025 (USD THOUSAND) 89
TABLE 15 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2021?2025 (USD THOUSAND) 89
TABLE 16 COMPANION ANIMAL DIAGNOSTICS MARKET: MAJOR CONFERENCES & EVENTS IN 2026?2027 90
TABLE 17 CASE STUDY 1: NGS-BASED LIQUID BIOPSY FOR CANINE CANCER DETECTION 93
TABLE 18 CASE STUDY 2: ADOPTION OF AI -ENABLED POC DIAGNOSTIC PLATFORM FOR PARASITE DETECTION 93
TABLE 19 CASE STUDY 3: MULTIPLEX ELISA-BASED POC DIAGNOSTIC TEST: TARGETING VECTOR-BORNE DISEASE DETECTION 94
TABLE 20 US-ADJUSTED RECIPROCAL TARIFF RATES 96
TABLE 21 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR COMPANION ANIMAL DIAGNOSTICS 97
TABLE 22 NORTH AMERICA: IMPACT ON CANADA DUE TO US TARIFFS 98
TABLE 23 ASIA PACIFIC: IMPACT ON CHINA, JAPAN, AND INDIA DUE TO US TARIFFS 98
TABLE 24 EUROPE: IMPACT ON GERMANY AND UK DUE TO US TARIFFS 99
TABLE 25 LATIN AMERICA: IMPACT ON MEXICO DUE TO US TARIFFS 99
TABLE 26 COMPANION ANIMAL DIAGNOSTICS MARKET: MAJOR PATENTS 107
TABLE 27 KEY COMPANIES IMPLEMENTING AI IN COMPANION ANIMAL DIAGNOSTICS MARKET 111
TABLE 28 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 113
TABLE 29 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 30 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR COMPANION ANIMAL DIAGNOSTICS PRODUCTS 119
TABLE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 121
TABLE 33 COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 125
TABLE 34 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC CONSUMABLES 126
TABLE 35 COMPANION ANIMAL DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 127
TABLE 36 KEY PLAYERS PROVIDING COMPANION ANIMAL DIAGNOSTIC INSTRUMENTS 128
TABLE 37 COMPANION ANIMAL DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 130
TABLE 38 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 132
TABLE 39 KEY PLAYERS PROVIDING IMMUNODIAGNOSTIC TECHNOLOGIES 133
TABLE 40 COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 134
TABLE 41 COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 135
TABLE 42 KEY PLAYERS PROVIDING LATERAL FLOW ASSAYS 136
TABLE 43 LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 136
TABLE 44 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 137
TABLE 45 KEY PLAYERS PROVIDING LATERAL FLOW RAPID TESTS 138
TABLE 46 RAPID TESTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 139
TABLE 47 RAPID TESTS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 140
TABLE 48 KEY PLAYERS PROVIDING LATERAL FLOW STRIP READERS 141
TABLE 49 STRIP READERS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 141
TABLE 50 STRIP READERS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 142
TABLE 51 KEY PLAYERS PROVIDING ELISA TESTS 143
TABLE 52 ELISA TESTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 144
TABLE 53 KEY PLAYERS PROVIDING ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 145
TABLE 54 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 146
TABLE 55 KEY PLAYERS PROVIDING IMMUNOASSAY ANALYZERS 147
TABLE 56 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 148
TABLE 57 KEY PLAYERS PROVIDING RADIOIMMUNOASSAYS 149
TABLE 58 RADIOIMMUNOASSAYS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 150
TABLE 59 OTHER IMMUNODIAGNOSTICS PRODUCTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 151
TABLE 60 KEY PLAYERS PROVIDING CLINICAL BIOCHEMISTRY PRODUCTS 152
TABLE 61 COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 153
TABLE 62 COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 154
TABLE 63 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYSIS 155
TABLE 64 CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE, 2024?2031 (USD MILLION) 156
TABLE 65 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 156
TABLE 66 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES 157
TABLE 67 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 158
TABLE 68 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 159
TABLE 69 KEY PLAYERS PROVIDING CLINICAL CHEMISTRY ANALYZERS 160
TABLE 70 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 160
TABLE 71 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION,
2024?2031 (THOUSAND UNITS) 161
TABLE 72 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYSIS 162
TABLE 73 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 162
TABLE 74 BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 163
TABLE 75 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS,
AND CARTRIDGES 164
TABLE 76 BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET,
BY COUNTRY, 2024?2031 (USD MILLION) 165
TABLE 77 BLOOD GAS & ELECTROLYTE REAGENTS, CLIPS, AND CARTRIDGES MARKET,
BY REGION, 2024?2031 (THOUSAND UNITS) 166
TABLE 78 KEY PLAYERS PROVIDING BLOOD GAS & ELECTROLYTE ANALYZERS 167
TABLE 79 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 167
TABLE 80 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY REGION,
2024?2031 (THOUSAND UNITS) 168
TABLE 81 KEY PLAYERS PROVIDING GLUCOSE MONITORING 169
TABLE 82 GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 169
TABLE 83 GLUCOSE MONITORING MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 170
TABLE 84 KEY PLAYERS PROVIDING BLOOD GLUCOSE STRIPS 171
TABLE 85 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 172
TABLE 86 BLOOD GLUCOSE STRIPS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 173
TABLE 87 KEY PLAYERS PROVIDING GLUCOSE MONITORS 174
TABLE 88 GLUCOSE MONITORS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 174
TABLE 89 GLUCOSE MONITORS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 175
TABLE 90 KEY PLAYERS PROVIDING URINE GLUCOSE STRIPS 176
TABLE 91 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 176
TABLE 92 URINE GLUCOSE STRIPS MARKET, BY REGION, 2024?2031 (THOUSAND UNITS) 177
TABLE 93 KEY PLAYERS PROVIDING MOLECULAR DIAGNOSTICS 178
TABLE 94 COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 179
TABLE 95 COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 179
TABLE 96 KEY PLAYERS PROVIDING PCR TESTS 181
TABLE 97 PCR TESTS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 182
TABLE 98 MICROARRAYS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 183
TABLE 99 NUCLEIC ACID SEQUENCING MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 185
TABLE 100 OTHER MOLECULAR DIAGNOSTICS PRODUCTS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 186
TABLE 101 KEY PLAYERS PROVIDING URINALYSIS PRODUCTS 187
TABLE 102 COMPANION ANIMAL URINALYSIS MARKET, BY TYPE, 2024?2031 (USD MILLION) 188
TABLE 103 COMPANION ANIMAL URINALYSIS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 188
TABLE 104 KEY PLAYERS PROVIDING URINALYSIS CLIPS & CARTRIDGES 190
TABLE 105 URINALYSIS CLIPS & CARTRIDGES MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 190
TABLE 106 KEY PLAYERS PROVIDING URINE ANALYZERS 192
TABLE 107 URINE ANALYZERS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 192
TABLE 108 KEY PLAYERS PROVIDING URINE TEST STRIPS 193
TABLE 109 URINE TEST STRIPS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 194
TABLE 110 KEY PLAYERS PROVIDING HEMATOLOGY PRODUCTS 195
TABLE 111 COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 196
TABLE 112 COMPANION ANIMAL HEMATOLOGY MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 196
TABLE 113 KEY PLAYERS PROVIDING HEMATOLOGY CARTRIDGES 197
TABLE 114 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 198
TABLE 115 KEY PLAYERS PROVIDING HEMATOLOGY ANALYZERS 199
TABLE 116 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 200
TABLE 117 KEY PLAYERS PROVIDING OTHER TECHNOLOGIES 201
TABLE 118 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 202
TABLE 119 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 204
TABLE 120 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY,
BY COUNTRY, 2024?2031 (USD MILLION) 206
TABLE 121 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY, BY COUNTRY, 2024?2031 (USD MILLION) 208
TABLE 122 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY,
2024?2031 (USD MILLION) 210
TABLE 123 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY, BY COUNTRY, 2024?2031 (USD MILLION) 212
TABLE 124 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2024?2031 (USD MILLION) 214
TABLE 125 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 216
TABLE 126 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS FOR DOGS 217
TABLE 127 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY,
2024?2031 (USD MILLION) 218
TABLE 128 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS FOR CATS 220
TABLE 129 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY,
2024?2031 (USD MILLION) 221
TABLE 130 KEY PLAYERS OFFERING COMPANION ANIMAL DIAGNOSTIC PRODUCTS
FOR HORSES 222
TABLE 131 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY,
2024?2031 (USD MILLION) 223
TABLE 132 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2024?2031 (USD MILLION) 225
TABLE 133 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 227
TABLE 134 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2024?2031 (USD MILLION) 228
TABLE 135 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY REFERENCE LABORATORIES, BY COUNTRY, 2024?2031 (USD MILLION) 230
TABLE 136 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2024?2031 (USD MILLION) 232
TABLE 137 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2024?2031 (USD MILLION) 234
TABLE 138 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION,
2024?2031 (USD MILLION) 236
TABLE 139 COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 237
TABLE 140 NORTH AMERICA: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024?2031 (THOUSAND UNITS) 240
TABLE 141 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2024?2031 (USD MILLION) 240
TABLE 142 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 241
TABLE 143 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 241
TABLE 144 NORTH AMERICA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 242
TABLE 145 NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY TYPE,
2024?2031 (USD MILLION) 242
TABLE 146 NORTH AMERICA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET,
BY TYPE, 2024?2031 (USD MILLION) 243
TABLE 147 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 243
TABLE 148 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY TYPE,
2024?2031 (USD MILLION) 243
TABLE 149 NORTH AMERICA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024?2031 (USD MILLION) 244
TABLE 150 NORTH AMERICA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 244
TABLE 151 NORTH AMERICA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 244
TABLE 152 NORTH AMERICA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 245
TABLE 153 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024?2031 (USD MILLION) 245
TABLE 154 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 246
TABLE 155 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024?2031 (USD MILLION) 246
TABLE 156 US: KEY MACROINDICATORS 247
TABLE 157 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 248
TABLE 158 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 248
TABLE 159 US: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 249
TABLE 160 US: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 249
TABLE 161 US: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 250
TABLE 162 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 250
TABLE 163 US: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 250
TABLE 164 US: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 165 US: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 166 US: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 251
TABLE 167 US: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 252
TABLE 168 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 252
TABLE 169 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 252
TABLE 170 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 253
TABLE 171 CANADA: KEY MACROINDICATORS 254
TABLE 172 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 254
TABLE 173 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 254
TABLE 174 CANADA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 255
TABLE 175 CANADA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 255
TABLE 176 CANADA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 256
TABLE 177 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 256
TABLE 178 CANADA: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 256
TABLE 179 CANADA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 257
TABLE 180 CANADA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 257
TABLE 181 CANADA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 257
TABLE 182 CANADA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 258
TABLE 183 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 258
TABLE 184 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 259
TABLE 185 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 259
TABLE 186 EUROPE: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024?2031 (THOUSAND UNITS) 261
TABLE 187 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 262
TABLE 188 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 262
TABLE 189 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 263
TABLE 190 EUROPE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 263
TABLE 191 EUROPE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 264
TABLE 192 EUROPE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 264
TABLE 193 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 264
TABLE 194 EUROPE: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 195 EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 265
TABLE 196 EUROPE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 265
TABLE 197 EUROPE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 266
TABLE 198 EUROPE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 266
TABLE 199 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 266
TABLE 200 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 267
TABLE 201 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 267
TABLE 202 GERMANY: KEY MACROINDICATORS 268
TABLE 203 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 269
TABLE 204 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 269
TABLE 205 GERMANY: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 270
TABLE 206 GERMANY: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 270
TABLE 207 GERMANY: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024?2031 (USD MILLION) 271
TABLE 208 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 271
TABLE 209 GERMANY: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 271
TABLE 210 GERMANY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 272
TABLE 211 GERMANY: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 272
TABLE 212 GERMANY: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 272
TABLE 213 GERMANY: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 273
TABLE 214 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 273
TABLE 215 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 274
TABLE 216 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 274
TABLE 217 UK: KEY MACROINDICATORS 276
TABLE 218 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 276
TABLE 219 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 276
TABLE 220 UK: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 277
TABLE 221 UK: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 277
TABLE 222 UK: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 278
TABLE 223 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 278
TABLE 224 UK: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 278
TABLE 225 UK: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 279
TABLE 226 UK: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 279
TABLE 227 UK: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 279
TABLE 228 UK: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 280
TABLE 229 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 280
TABLE 230 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 280
TABLE 231 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 281
TABLE 232 FRANCE: KEY MACROINDICATORS 282
TABLE 233 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 282
TABLE 234 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 282
TABLE 235 FRANCE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 283
TABLE 236 FRANCE: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 283
TABLE 237 FRANCE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 238 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 284
TABLE 239 FRANCE: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 284
TABLE 240 FRANCE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 241 FRANCE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 285
TABLE 242 FRANCE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 285
TABLE 243 FRANCE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 286
TABLE 244 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 286
TABLE 245 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 286
TABLE 246 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 287
TABLE 247 ITALY: KEY MACROINDICATORS 288
TABLE 248 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 288
TABLE 249 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 289
TABLE 250 ITALY: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 289
TABLE 251 ITALY: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 290
TABLE 252 ITALY: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 290
TABLE 253 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 290
TABLE 254 ITALY: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 291
TABLE 255 ITALY: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 291
TABLE 256 ITALY: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 291
TABLE 257 ITALY: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 292
TABLE 258 ITALY: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 292
TABLE 259 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 292
TABLE 260 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 293
TABLE 261 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 293
TABLE 262 SPAIN: KEY MACROINDICATORS 294
TABLE 263 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 295
TABLE 264 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 295
TABLE 265 SPAIN: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 296
TABLE 266 SPAIN: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 296
TABLE 267 SPAIN: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 297
TABLE 268 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 297
TABLE 269 SPAIN: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 297
TABLE 270 SPAIN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 298
TABLE 271 SPAIN: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 298
TABLE 272 SPAIN: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 298
TABLE 273 SPAIN: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 299
TABLE 274 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 299
TABLE 275 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 299
TABLE 276 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 300
TABLE 277 NETHERLANDS: KEY MACROINDICATORS 301
TABLE 278 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 301
TABLE 279 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 301
TABLE 280 NETHERLANDS: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 302
TABLE 281 NETHERLANDS: LATERAL FLOW ASSAYS MARKET, BY TYPE,
2024?2031 (USD MILLION) 302
TABLE 282 NETHERLANDS: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024?2031 (USD MILLION) 303
TABLE 283 NETHERLANDS: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 303
TABLE 284 NETHERLANDS: GLUCOSE MONITORING MARKET, BY TYPE,
2024?2031 (USD MILLION) 303
TABLE 285 NETHERLANDS: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 304
TABLE 286 NETHERLANDS: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 304
TABLE 287 NETHERLANDS: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 304
TABLE 288 NETHERLANDS: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 305
TABLE 289 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024?2031 (USD MILLION) 305
TABLE 290 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 305
TABLE 291 NETHERLANDS: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024?2031 (USD MILLION) 306
TABLE 292 SWEDEN: KEY MACROINDICATORS 307
TABLE 293 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 307
TABLE 294 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 307
TABLE 295 SWEDEN: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 308
TABLE 296 SWEDEN: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 308
TABLE 297 SWEDEN: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024?2031 (USD MILLION) 309
TABLE 298 SWEDEN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 309
TABLE 299 SWEDEN: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 309
TABLE 300 SWEDEN: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 310
TABLE 301 SWEDEN: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 310
TABLE 302 SWEDEN: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 310
TABLE 303 SWEDEN: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 311
TABLE 304 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 311
TABLE 305 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 311TABLE 306 SWEDEN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 312
TABLE 307 POLAND: KEY MACROINDICATORS 313
TABLE 308 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 313
TABLE 309 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 313
TABLE 310 POLAND: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 314
TABLE 311 POLAND: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 314
TABLE 312 POLAND: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 315
TABLE 313 POLAND: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 315
TABLE 314 POLAND: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 315
TABLE 315 POLAND: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 316
TABLE 316 POLAND: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 316
TABLE 317 POLAND: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 316
TABLE 318 POLAND: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 317
TABLE 319 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 317
TABLE 320 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 317
TABLE 321 POLAND: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 318
TABLE 322 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT, 2024?2031 (USD MILLION) 319
TABLE 323 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 319
TABLE 324 REST OF EUROPE: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 320
TABLE 325 REST OF EUROPE: LATERAL FLOW ASSAYS MARKET, BY TYPE,
2024?2031 (USD MILLION) 320
TABLE 326 REST OF EUROPE: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET,
BY TYPE, 2024?2031 (USD MILLION) 321
TABLE 327 REST OF EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 321
TABLE 328 REST OF EUROPE: GLUCOSE MONITORING MARKET, BY TYPE,
2024?2031 (USD MILLION) 321
TABLE 329 REST OF EUROPE: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE, 2024?2031 (USD MILLION) 322
TABLE 330 REST OF EUROPE: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET,
BY TYPE, 2024?2031 (USD MILLION) 322
TABLE 331 REST OF EUROPE: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 322
TABLE 332 REST OF EUROPE: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 323
TABLE 333 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024?2031 (USD MILLION) 323
TABLE 334 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 323
TABLE 335 REST OF EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024?2031 (USD MILLION) 324
TABLE 336 ASIA PACIFIC: VOLUME ANALYSIS OF COMPANION ANIMAL DIAGNOSTIC PRODUCTS, 2024?2031 (THOUSAND UNITS) 327
TABLE 337 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2024?2031 (USD MILLION) 328
TABLE 338 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 328
TABLE 339 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2024?2031 (USD MILLION) 329
TABLE 340 ASIA PACIFIC: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 329
TABLE 341 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY TYPE,
2024?2031 (USD MILLION) 330
TABLE 342 ASIA PACIFIC: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2024?2031 (USD MILLION) 330
TABLE 343 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 330
TABLE 344 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY TYPE,
2024?2031 (USD MILLION) 331
TABLE 345 ASIA PACIFIC: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 331
TABLE 346 ASIA PACIFIC: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2024?2031 (USD MILLION) 331
TABLE 347 ASIA PACIFIC: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 332
TABLE 348 ASIA PACIFIC: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 332
TABLE 349 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2024?2031 (USD MILLION) 332
TABLE 350 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2024?2031 (USD MILLION) 333
TABLE 351 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 333
TABLE 352 CHINA: KEY MACROINDICATORS 334
TABLE 353 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD MILLION) 335
TABLE 354 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2024?2031 (USD MILLION) 335
TABLE 355 CHINA: COMPANION ANIMAL IMMUNODIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 336
TABLE 356 CHINA: LATERAL FLOW ASSAYS MARKET, BY TYPE, 2024?2031 (USD MILLION) 336
TABLE 357 CHINA: COMPANION ANIMAL CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2024?2031 (USD MILLION) 336
TABLE 358 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 337
TABLE 359 CHINA: GLUCOSE MONITORING MARKET, BY TYPE, 2024?2031 (USD MILLION) 337
TABLE 360 CHINA: BLOOD GAS & ELECTROLYTE ANALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 337
TABLE 361 CHINA: COMPANION ANIMAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE,
2024?2031 (USD MILLION) 338
TABLE 362 CHINA: COMPANION ANIMAL URINALYSIS MARKET, BY TYPE,
2024?2031 (USD MILLION) 338
TABLE 363 CHINA: COMPANION ANIMAL HEMATOLOGY MARKET, BY TYPE,
2024?2031 (USD MILLION) 338
TABLE 364 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2024?2031 (USD MILLION) 339
TABLE 365 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2024?2031 (USD MILLION) 339
TABLE 366 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2024?2031 (USD MILLION) 340
TABLE 367 JAPAN: KEY MACROINDICATORS 341
TABLE 368 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY PRODUCT,
2024?2031 (USD